CLINICAL_TRIALS
trial_result
· 2017-06-19
Clinical Trial Update: Intrathecal Hydromorphone for Post-cesarean Delivery Pain - a Dose Finding Study [Phase 4]
Summary
Phase 4 dose-finding trial evaluating intrathecal hydromorphone for post-cesarean delivery pain was terminated; results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Brigham and Women's Hospital | Conditions: Healthy, Pain | Phase 4 | Status: TERMINATED | Results posted: 2017-06-19